# Franklin Electric Co Inc: financial statements, quarterly

FELE · Nasdaq · CIK 38725 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fele.md) · [Financials](/companies/fele/financials.md) · [Filings](/companies/fele/filings.md) · [Insiders](/companies/fele/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fele/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [569](/filings/0000038725-24-000143.md) | [538](/filings/0000038725-24-000167.md) | [473 d](/filings/0000038725-26-000009.md) | [461](/filings/0000038725-25-000084.md) | [543](/filings/0000038725-25-000162.md) | [531](/filings/0000038725-25-000178.md) | [486 d](/filings/0000038725-26-000009.md) | [455](/filings/0000038725-26-000026.md) | [587](/filings/0000038725-25-000162.md) | [582](/filings/0000038725-25-000178.md) | [507 d](/filings/0000038725-26-000009.md) | [500](/filings/0000038725-26-000026.md) |
| Cost of revenue | $m | [381](/filings/0000038725-24-000143.md) | [352](/filings/0000038725-24-000167.md) | [313 d](/filings/0000038725-26-000009.md) | [297](/filings/0000038725-25-000084.md) | [343](/filings/0000038725-25-000162.md) | [342](/filings/0000038725-25-000178.md) | [322 d](/filings/0000038725-26-000009.md) | [291](/filings/0000038725-26-000026.md) | [376](/filings/0000038725-25-000162.md) | [373](/filings/0000038725-25-000178.md) | [335 d](/filings/0000038725-26-000009.md) | [325](/filings/0000038725-26-000026.md) |
| Gross profit | $m | [188](/filings/0000038725-24-000143.md) | [186](/filings/0000038725-24-000167.md) | [160 d](/filings/0000038725-26-000009.md) | [164](/filings/0000038725-25-000084.md) | [200](/filings/0000038725-25-000162.md) | [190](/filings/0000038725-25-000178.md) | [164 d](/filings/0000038725-26-000009.md) | [164](/filings/0000038725-26-000026.md) | [212](/filings/0000038725-25-000162.md) | [209](/filings/0000038725-25-000178.md) | [171 d](/filings/0000038725-26-000009.md) | [175](/filings/0000038725-26-000026.md) |
| Selling, general and administrative | $m | [107](/filings/0000038725-24-000143.md) | [108](/filings/0000038725-24-000167.md) | [109 d](/filings/0000038725-26-000009.md) | [116](/filings/0000038725-25-000084.md) | [121](/filings/0000038725-25-000162.md) | [116](/filings/0000038725-25-000178.md) | [118 d](/filings/0000038725-26-000009.md) | [120](/filings/0000038725-26-000026.md) | [124](/filings/0000038725-25-000162.md) | [123](/filings/0000038725-25-000178.md) | [120 d](/filings/0000038725-26-000009.md) | [123](/filings/0000038725-26-000026.md) |
| Operating income | $m | [80.9](/filings/0000038725-24-000143.md) | [78.1](/filings/0000038725-24-000167.md) | [50.8 d](/filings/0000038725-26-000009.md) | [47.9](/filings/0000038725-25-000084.md) | [79.1](/filings/0000038725-25-000162.md) | [73.5](/filings/0000038725-25-000178.md) | [43.0 d](/filings/0000038725-26-000009.md) | [44.1](/filings/0000038725-26-000026.md) | [88.1](/filings/0000038725-25-000162.md) | [85.1](/filings/0000038725-25-000178.md) | [51.6 d](/filings/0000038725-26-000009.md) | [48.1](/filings/0000038725-26-000026.md) |
| Interest expense | $m | [4.2](/filings/0000038725-24-000143.md) | [3.0](/filings/0000038725-24-000167.md) | [1.5 d](/filings/0000038725-26-000009.md) | [1.4](/filings/0000038725-25-000084.md) | [2.0](/filings/0000038725-25-000162.md) | [1.6](/filings/0000038725-25-000178.md) | [1.3 d](/filings/0000038725-26-000009.md) | [1.8](/filings/0000038725-26-000026.md) | [2.8](/filings/0000038725-25-000162.md) | [3.5](/filings/0000038725-25-000178.md) | [2.5 d](/filings/0000038725-26-000009.md) | [2.3](/filings/0000038725-26-000026.md) |
| Income tax | $m | [14.2](/filings/0000038725-24-000143.md) | [14.7](/filings/0000038725-24-000167.md) | [8.3 d](/filings/0000038725-26-000009.md) | [9.2](/filings/0000038725-25-000084.md) | [17.6](/filings/0000038725-25-000162.md) | [17.0](/filings/0000038725-25-000178.md) | [6.4 d](/filings/0000038725-26-000009.md) | [10.5](/filings/0000038725-26-000026.md) | [20.1](/filings/0000038725-25-000162.md) | [6.3](/filings/0000038725-25-000178.md) | [9.1 d](/filings/0000038725-26-000009.md) | [11.1](/filings/0000038725-26-000026.md) |
| Net income | $m | [59.6](/filings/0000038725-24-000143.md) | [57.8](/filings/0000038725-24-000167.md) | [38.5 d](/filings/0000038725-26-000009.md) | [33.0](/filings/0000038725-25-000084.md) | [59.1](/filings/0000038725-25-000162.md) | [54.6](/filings/0000038725-25-000178.md) | [33.7 d](/filings/0000038725-26-000009.md) | [31.0](/filings/0000038725-26-000026.md) | [60.1](/filings/0000038725-25-000162.md) | [16.7](/filings/0000038725-25-000178.md) | [39.3 d](/filings/0000038725-26-000009.md) | [34.3](/filings/0000038725-26-000026.md) |
| Diluted EPS | $ per share | [1.27](/filings/0000038725-24-000143.md) | [1.23](/filings/0000038725-24-000167.md) | not reported | [0.70](/filings/0000038725-25-000084.md) | [1.26](/filings/0000038725-25-000162.md) | [1.17](/filings/0000038725-25-000178.md) | not reported | [0.67](/filings/0000038725-26-000026.md) | [1.31](/filings/0000038725-25-000162.md) | [0.37](/filings/0000038725-25-000178.md) | not reported | [0.77](/filings/0000038725-26-000026.md) |
| Basic EPS | $ per share | [1.29](/filings/0000038725-24-000143.md) | [1.25](/filings/0000038725-24-000167.md) | not reported | [0.71](/filings/0000038725-25-000084.md) | [1.28](/filings/0000038725-25-000162.md) | [1.19](/filings/0000038725-25-000178.md) | not reported | [0.67](/filings/0000038725-26-000026.md) | [1.32](/filings/0000038725-25-000162.md) | [0.37](/filings/0000038725-25-000178.md) | not reported | [0.77](/filings/0000038725-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [53.2](/filings/0000038725-23-000151.md) | [62.5](/filings/0000038725-23-000182.md) | [85.0](/filings/0000038725-25-000026.md) | [65.3](/filings/0000038725-24-000078.md) | [58.1](/filings/0000038725-24-000143.md) | [106](/filings/0000038725-24-000167.md) | [221](/filings/0000038725-26-000009.md) | [84.0](/filings/0000038725-25-000084.md) | [105](/filings/0000038725-25-000162.md) | [103](/filings/0000038725-25-000178.md) | [99.7](/filings/0000038725-26-000026.md) | [80.4](/filings/0000038725-26-000026.md) |
| Current assets | $m | [966](/filings/0000038725-23-000151.md) | [899](/filings/0000038725-23-000182.md) | [854](/filings/0000038725-25-000026.md) | [901](/filings/0000038725-24-000078.md) | [919](/filings/0000038725-24-000143.md) | [942](/filings/0000038725-24-000167.md) | [964](/filings/0000038725-26-000009.md) | [957](/filings/0000038725-25-000084.md) | [1,036](/filings/0000038725-25-000162.md) | [1,017](/filings/0000038725-25-000178.md) | [959](/filings/0000038725-26-000026.md) | [1,015](/filings/0000038725-26-000026.md) |
| Total assets | $m | [1,803](/filings/0000038725-23-000151.md) | [1,725](/filings/0000038725-23-000182.md) | [1,728](/filings/0000038725-26-000009.md) | [1,773](/filings/0000038725-25-000084.md) | [1,784](/filings/0000038725-25-000162.md) | [1,807](/filings/0000038725-25-000178.md) | [1,821](/filings/0000038725-26-000009.md) | [1,929](/filings/0000038725-26-000026.md) | [2,018](/filings/0000038725-25-000162.md) | [1,997](/filings/0000038725-25-000178.md) | [1,944](/filings/0000038725-26-000026.md) | [1,997](/filings/0000038725-26-000026.md) |
| Current liabilities | $m | [433](/filings/0000038725-23-000151.md) | [328](/filings/0000038725-23-000182.md) | [287](/filings/0000038725-25-000026.md) | [316](/filings/0000038725-24-000078.md) | [346](/filings/0000038725-24-000143.md) | [393](/filings/0000038725-24-000167.md) | [434](/filings/0000038725-26-000009.md) | [484](/filings/0000038725-25-000084.md) | [604](/filings/0000038725-25-000162.md) | [401](/filings/0000038725-25-000178.md) | [344](/filings/0000038725-26-000026.md) | [380](/filings/0000038725-26-000026.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [160](/filings/0000038725-23-000151.md) | [40.4](/filings/0000038725-23-000182.md) | [12.4](/filings/0000038725-25-000026.md) | [24.4](/filings/0000038725-24-000078.md) | [42.4](/filings/0000038725-24-000143.md) | [76.4](/filings/0000038725-24-000167.md) | [118](/filings/0000038725-26-000009.md) | [150](/filings/0000038725-25-000084.md) | [270](/filings/0000038725-25-000162.md) | [69.1](/filings/0000038725-25-000178.md) | [31.8](/filings/0000038725-26-000026.md) | [89.8](/filings/0000038725-26-000026.md) |
| Shareholders' equity | $m | [1,147](/filings/0000038725-23-000151.md) | [1,180](/filings/0000038725-23-000182.md) | [1,207](/filings/0000038725-25-000026.md) | [1,220](/filings/0000038725-24-000078.md) | [1,222](/filings/0000038725-24-000143.md) | [1,270](/filings/0000038725-24-000167.md) | [1,266](/filings/0000038725-26-000009.md) | [1,297](/filings/0000038725-25-000084.md) | [1,262](/filings/0000038725-25-000162.md) | [1,318](/filings/0000038725-25-000178.md) | [1,323](/filings/0000038725-26-000026.md) | [1,340](/filings/0000038725-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [55.0 d](/filings/0000038725-24-000143.md) | [156 d](/filings/0000038725-24-000167.md) | [117 d](/filings/0000038725-26-000009.md) | [(1.4)](/filings/0000038725-25-000084.md) | [36.4 d](/filings/0000038725-25-000162.md) | [116 d](/filings/0000038725-25-000178.md) | [110 d](/filings/0000038725-26-000009.md) | [(19.5)](/filings/0000038725-26-000026.md) | [51.5 d](/filings/0000038725-25-000162.md) | [103 d](/filings/0000038725-25-000178.md) | [104 d](/filings/0000038725-26-000009.md) | [(40.9)](/filings/0000038725-26-000026.md) |
| Capital expenditure | $m | [10.7 d](/filings/0000038725-24-000143.md) | [9.9 d](/filings/0000038725-24-000167.md) | [11.3 d](/filings/0000038725-26-000009.md) | [9.2](/filings/0000038725-25-000084.md) | [10.3 d](/filings/0000038725-25-000162.md) | [9.5 d](/filings/0000038725-25-000178.md) | [12.8 d](/filings/0000038725-26-000009.md) | [6.8](/filings/0000038725-26-000026.md) | [11.6 d](/filings/0000038725-25-000162.md) | [11.4 d](/filings/0000038725-25-000178.md) | [15.5 d](/filings/0000038725-26-000009.md) | [9.5](/filings/0000038725-26-000026.md) |
| Dividends paid | $m | [10.4 d](/filings/0000038725-24-000143.md) | [10.4 d](/filings/0000038725-24-000167.md) | [10.4 d](/filings/0000038725-26-000009.md) | [12.4](/filings/0000038725-25-000084.md) | [11.6 d](/filings/0000038725-25-000162.md) | [11.5 d](/filings/0000038725-25-000178.md) | [11.4 d](/filings/0000038725-26-000009.md) | [13.2](/filings/0000038725-26-000026.md) | [12.2 d](/filings/0000038725-25-000162.md) | [11.9 d](/filings/0000038725-25-000178.md) | [12.8 d](/filings/0000038725-26-000009.md) | [12.4](/filings/0000038725-26-000026.md) |
| Share repurchases | $m | [8.4 d](/filings/0000038725-24-000143.md) | [4.3 d](/filings/0000038725-24-000167.md) | [13.4 d](/filings/0000038725-26-000009.md) | [9.0](/filings/0000038725-25-000084.md) | [38.8 d](/filings/0000038725-25-000162.md) | [9.1 d](/filings/0000038725-25-000178.md) | [4.1 d](/filings/0000038725-26-000009.md) | [6.9](/filings/0000038725-26-000026.md) | [122 d](/filings/0000038725-25-000162.md) | [0.1 d](/filings/0000038725-25-000178.md) | [36.2 d](/filings/0000038725-26-000009.md) | [13.2](/filings/0000038725-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.9](/filings/0000038725-23-000151.md) | [47.0](/filings/0000038725-23-000182.md) | [46.9](/filings/0000038725-24-000078.md) | [46.9](/filings/0000038725-24-000143.md) | [46.9](/filings/0000038725-24-000167.md) | [46.7](/filings/0000038725-25-000084.md) | [46.6](/filings/0000038725-25-000162.md) | [46.3](/filings/0000038725-25-000178.md) | [46.3](/filings/0000038725-26-000026.md) | [45.9](/filings/0000038725-25-000162.md) | [45.0](/filings/0000038725-25-000178.md) | [44.7](/filings/0000038725-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 44,182,232 at 2026-04-23, from the cover of the [10-Q filed 2026-04-29](/filings/0000038725-26-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.